Fragment Based Drug Discovery (FBDD) has been established as an efficient tool in search of more accessible drug-like chemical space. Our FBDD group has developed a unique and well-designed fragment library with superb structural novelty and diversity based on our building block collections. The FBDD service at PharmaBlock is committed to providing effective and high-quality drug discovery solutions to clients.

• The molecular weight is ≤300 Da
• Number of hydrogen-bond donors ≤3
• Number of hydrogen-bond acceptors ≤3
• The LogP is ≤3
• Number of rotatable bonds (NROT) ≤3

> 6000 fragments and growing daily